| Cabazitaxel studied in …STUDIED_INderived104 of 104show fewer |
|---|
| → studied in | NCT05818683Phase 1 · recruiting A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213674Phase 3 · recruiting A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06085729Phase 1/Phase 2 · recruiting Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06353386Phase 1/Phase 2 · recruiting Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) · 104 trials list this drug (19 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02522715Phase 1/Phase 2 · active not recruiting Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02703623Phase 2 · active not recruiting Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Prostate Adenocarcinoma,Prostate Carcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04592237Phase 2 · active not recruiting Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer · 104 trials list this drug (19 active) | — | — | Prostate Neuroendocrine Carcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06632977Phase 2 · recruiting Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07611110Phase 3 · recruiting AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03419234Phase 2 · active not recruiting Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel · 104 trials list this drug (19 active) | — | — | Prostate Adenocarcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03048942Phase 2 · completed Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer · 104 trials list this drug (19 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03263650Phase 2 · completed Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC · 104 trials list this drug (19 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03934840Phase 2 · completed CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06691984Phase 3 · active not recruiting Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute) · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02115165Phase 2 · completed A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors · 104 trials list this drug (19 active) | — | — | Non-Seminomatous Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04709276Phase 2 · active not recruiting A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer · 104 trials list this drug (19 active) | — | — | Prostate Neuroendocrine Carcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02044354Phase 3 · completed Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701007completed Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470243Phase 3 · recruiting Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02985957Phase 2 · completed A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650) · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01952223Phase 3 · active not recruiting A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse · 104 trials list this drug (19 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01420250Phase 1 · completed Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01437488Phase 2 · completed Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy · 104 trials list this drug (19 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03903835Phase 3 · recruiting ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05340374Phase 1/Phase 2 · active not recruiting Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06890832Phase 2 · not yet recruiting A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02202772Phase 1/Phase 2 · active not recruiting Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder · 104 trials list this drug (19 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02218606Phase 2 · completed Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05563558Phase 2 · recruiting Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS) · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 104 trials list this drug (19 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02903160Phase 2 · completed Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02478502Phase 2 · terminated Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer · 104 trials list this drug (19 active) | — | — | Malignant Testicular Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04495179Phase 2 · completed A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC. · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03114254Phase 2 · completed A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis · 104 trials list this drug (19 active) | — | — | Penile Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03392428Phase 2 · completed A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02485691Phase 4 · completed Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02961257Phase 3 · completed Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03295565Phase 2/Phase 3 · completed Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01650285Phase 2 · terminated Cabazitaxel and Radiation For Patients With Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03101046Phase 2 · completed Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic · 104 trials list this drug (19 active) | — | — | Prostate Carcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01913652Phase 2 · completed Ph II Cabazitaxel DD Liposarcoma · 104 trials list this drug (19 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050866Phase 2 · unknown Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs) · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01505868Phase 1/Phase 2 · completed Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Prostate Adenocarcinoma,Prostate Carcinoma,Prostate Small Cell Neuroendocrine Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01620242Phase 2 · completed A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes · 104 trials list this drug (19 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02844582Phase 2 · terminated Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04622761Phase 2 · unknown Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03419442completed Multi-academic Center Study of Xofigo Patients · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02560337Phase 2 · completed Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy. · 104 trials list this drug (19 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043989Phase 1 · terminated Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02512458Phase 2 · completed Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02379390Phase 2 · terminated Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01308567Phase 3 · completed Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01365130Phase 2 · terminated Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen · 104 trials list this drug (19 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01668459Phase 2/Phase 3 · completed Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel · 104 trials list this drug (19 active) | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01845792Phase 2 · terminated Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01956149Phase 2 · completed Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer · 104 trials list this drug (19 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03257891Phase 2 · unknown Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines · 104 trials list this drug (19 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01757171Phase 2 · completed Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma · 104 trials list this drug (19 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02166658Phase 2 · terminated A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet) · 104 trials list this drug (19 active) | — | — | Malignant Breast Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01740570Phase 1/Phase 2 · withdrawn Phase I/II Cabazitaxel for Recurrent Malignant Glioma · 104 trials list this drug (19 active) | — | — | Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03356912Phase 2 · unknown CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02254785Phase 2 · unknown Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01718353Phase 2 · completed Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01866449Phase 2 · completed Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme · 104 trials list this drug (19 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01693549Phase 2 · completed Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes · 104 trials list this drug (19 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01594918Phase 1 · completed Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01518283Phase 2 · completed Study of Weekly Cabazitaxel for Advanced Prostate Cancer · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01934894Phase 2 · terminated Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01528163Phase 2 · completed Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · 104 trials list this drug (19 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01308580Phase 3 · completed Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02441894Phase 4 · completed Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01083615Phase 3 · terminated A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01578655Phase 3 · completed Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01447225Phase 1 · completed Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors · 104 trials list this drug (19 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02621190Phase 2 · withdrawn Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCs · 104 trials list this drug (19 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01751308Phase 1/Phase 2 · completed Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01511536Phase 1/Phase 2 · completed Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01649635Phase 4 · completed Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02074137Phase 4 · completed Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02035124Phase 2 · withdrawn Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01541007Phase 2 · completed A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer · 104 trials list this drug (19 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01852578Phase 2 · completed Cabazitaxel in Relapsed and Metastatic NSCLC · 104 trials list this drug (19 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01140607Phase 1 · completed Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment · 104 trials list this drug (19 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01600339Phase 2 · completed A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC) · 104 trials list this drug (19 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01500720Phase 2 · completed Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer · 104 trials list this drug (19 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01379339Phase 1 · completed Cabazitaxel - PF Induction Chemotherapy · 104 trials list this drug (19 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254279Phase 3 · completed Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01324583Phase 1 · completed Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01747239Phase 2 · terminated Cabazitaxel in Platinum Refractory Ovarian Cancer · 104 trials list this drug (19 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01469338Phase 2 · terminated Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01497964Phase 1/Phase 2 · completed Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy · 104 trials list this drug (19 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01531205Phase 2 · terminated Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA · 104 trials list this drug (19 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02204332Phase 2 · terminated Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment · 104 trials list this drug (19 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01913067Phase 2 · withdrawn Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC · 104 trials list this drug (19 active) | — | — | Malignant Breast Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01981668Phase 1 · withdrawn The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation · 104 trials list this drug (19 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01830231Phase 2/Phase 3 · unknown Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU) · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01576029Phase 2 · completed Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer · 104 trials list this drug (19 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01527929Phase 1 · completed Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment · 104 trials list this drug (19 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01750866Phase 2 · withdrawn Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer · 104 trials list this drug (19 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01001221Phase 1/Phase 2 · terminated Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor · 104 trials list this drug (19 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00925743Phase 1 · completed A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer · 104 trials list this drug (19 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01755390Phase 1 · completed A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors · 104 trials list this drug (19 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01087021Phase 1 · completed Effect of Cabazitaxel on the QTc Interval in Cancer Patients · 104 trials list this drug (19 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00417079Phase 3 · completed XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer · 104 trials list this drug (19 active) | — | — | Neoplasm,Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |